Skip to main content
editorial
. 2005 Jun 11;330(7504):1342–1343. doi: 10.1136/bmj.330.7504.1342

Figure 1.

Figure 1

Facsimile of pages 1 and 2 of the Food and Drug Administration (FDA) statistical review and evaluation of valdecoxib.w2 Publicly available at www.fda.gov/cder/foi/nda/2001/21-341_Bextra_statr_P1.pdf (accessed 20 May 2005)